Ensysce Biosciences, Inc.
ENSC
$2.11
$0.052.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.73M | -1.95M | -3.56M | 661.80K | -1.97M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 25.70K |
| Total Other Non-Cash Items | 251.40K | 55.40K | 47.80K | 18.50K | 20.30K |
| Change in Net Operating Assets | -1.22M | 182.80K | 2.75M | -1.70M | -388.40K |
| Cash from Operations | -2.71M | -1.71M | -764.10K | -1.02M | -2.31M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.10K | -47.20K | -96.30K | -71.40K | -51.20K |
| Issuance of Common Stock | 42.90K | 1.45M | 357.90K | 1.67M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.85M | -143.00K | -149.00K | 2.53M | 0.00 |
| Cash from Financing | 1.87M | 1.26M | 112.60K | 4.13M | -51.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -840.90K | -449.60K | -651.50K | 3.11M | -2.36M |